Stocks360

HEXO Corp. (HEXO.TO)

Stock analysis · TSX · Healthcare · Drug Manufacturers - Specialty & Generic

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
2.13
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

HEXO Corp. (HEXO.TO) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent
Jun 14, 2023
EPS $-2.68 vs est. $-0.01
Missed by $2.67

Proprietary Signals

Signal snapshot temporarily unavailable.

About HEXO Corp.

Operating through its various subsidiaries, HEXO Corp. engages in the cultivation, marketing, and distribution of cannabis products across Canada. Its comprehensive product line includes both recreational and medicinal cannabis, primarily sold under the HEXO brand. Furthermore, the company diversifies its offerings with cannabis-infused beverages from labels such as Little Victory, House of Terpenes, Mollo, Veryvell, and XMG, alongside other cannabis products available under the UP Cannabis, Original Stash, and Up brand names. HEXO Corp. also maintains a key strategic partnership with Tilray Brands, Inc. Established in 2013, the company initially operated as The Hydropothecary Corporation until it officially rebranded to HEXO Corp. in August 2018. Its corporate headquarters are situated in Gatineau, Canada.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap